Filana Therapeutics
FLNA
68 hedge funds and large institutions have $77.4M invested in Filana Therapeutics in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 5 closing their positions.
340% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 5
319% more capital invested
Capital invested by funds: $18.5M → $77.4M (+$59M)
83% more call options, than puts
Call options by funds: $7.35M | Put options by funds: $4.01M
33% more funds holding
Funds holding: 51 → 68 (+17)
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
3.16% more ownership
Funds ownership: 24.19% → 27.35% (+3.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
ExodusPoint Capital Management
New York
|
+$1.3M |
| 2 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
+$705K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$686K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$564K |
| 5 |
State Street
Boston,
Massachusetts
|
+$531K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
-$1.65M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$444K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$427K |
| 4 |
Jane Street
New York
|
-$366K |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$146K |
FLNA Hedge Fund Activity: Q3 2020 in Review
68 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2020, worth a combined $77.4M — up 319% from $18.5M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new FLNA positions and 5 closed out — a net gain of 17 holders — while 19 added to existing stakes and 15 trimmed.
The largest buyer was ExodusPoint Capital Management, opening a new position worth an estimated $1.3M. The largest seller was Bleichroeder LP, cutting an estimated $1.65M.
- 68 institutional investors held Filana Therapeutics (FLNA) as of Q3 2020, up from 51 in Q2 2020.
- Funds reported $77.4M of Filana Therapeutics stock for Q3 2020, up 319% quarter-over-quarter.
- 22 funds opened new Filana Therapeutics positions in Q3 2020 and 5 closed out, a net change of +17 holders.
- The largest Filana Therapeutics buyer in Q3 2020 was ExodusPoint Capital Management, an estimated $1.3M added.
- The largest Filana Therapeutics seller in Q3 2020 was Bleichroeder LP, an estimated $1.65M sold.
Based on aggregated 13F filings for Q3 2020.